You can buy or sell NBY and other stocks, options, ETFs, and crypto commission-free!
NovaBay Pharmaceuticals, Inc., also called NovaBay Pharmaceuticals, is a biopharmaceutical company, which engages in developing products for the eye care market. Its products include Avenova, NeutroPhase, and CelleRx. Read More The company was founded by Ramin Najafi on January 19, 2000 and is headquartered in Emeryville, CA.
52 Week High
52 Week Low
Seeking AlphaMay 9
NovaBay Pharmaceuticals, Inc CEO Justin Hall on Q1 2019 Results - Earnings Call Transcript
NovaBay Pharmaceuticals, Inc (NYSEMKT:NBY) Q1 2019 Earnings Conference Call May 9, 2019 4:30 PM ET Company Participants Bruce Voss - Investor Relations, LHA Justin Hall - Interim President & Chief Executive Officer Jason Raleigh - Interim Chief Financial Officer Conference Call Participants Ed Woo - Ascendiant Capital Operator Welcome to the NovaBay 2019 First Quarter Financial Results Conference Call. At this time, all participants are in a listen-only mode. Following management's prepared remarks,...
-$0.11 per share
-$0.28 per share